ask="3.50"
ask_size="1000"
average_daily_volume="57852"
bid="2.41"
bid_size="100"
book_value="1.19"
change="+0.32"
change_from_200_day_moving_average="-1.12"
change_from_50_day_moving_average="-0.38"
change_from_52_week_high="-3.43"
change_From_52_week_low="0.42"
change_in_percent="+11.76%"
close="3.04"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-3.90"
ebitda="-15.74M"
eps_estimate_current_year="-3.71"
eps_estimate_next_quarter="0.00"
eps_estimate_next_year="-2.81"
ex_dividend_date="N/A"
float_shares="5652000"
high="3.34"
high_52_weeks="6.47"
last_trade_date="1/27/2017"
last_trade_price="3.04"
last_trade_size="323"
last_trade_time="3:59pm"
low="2.67"
low_52_weeks="2.62"
market_capitalization="19.14M"
moving_average_200_day="4.16"
moving_average_50_day="3.42"
name="MABVAX THERAPEUTICS"
notes="N/A"
one_year_target_price="18.00"
open="2.67"
pe_ratio="N/A"
peg_ratio="-0.01"
percent_change_from_200_day_moving_average="-26.97%"
percent_change_from_50_day_moving_average="-11.06%"
percent_change_from_52_week_high="-53.05%"
percent_change_from_52_week_low="+16.03%"
previous_close="2.72"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.28"
price_per_sales="18.91"
revenue="905615.00"
shares_outstanding="6296000"
short_ratio="5.29"
stock_exchange="NCM"
symbol="MBVX"
volume="82204"
weeks_range_52="2.62 - 6.47"
